Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alpha Administration in Patients With COVID19-induced ARDS (COVIDORNASE)
Conditions: COVID-19; Acute Respiratory Distress Syndrome Interventions: Drug: Dornase Alfa Inhalation Solution [Pulmozyme]; Procedure: standard procedure Sponsors: Fondation Ophtalmologique Adolphe de Rothschild; University Hospital, Strasbourg, France Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials